WEINHOFF GREGORY M (Chief Financial Officer) received a stock award from CENTESSA PHARMACEUTICALS PLC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/3/2026ACC: 0001470831-26-000090
Officer· Chief Financial Officer
Since May 2021
+139.84K
Net shares
Net buyer
$347.9K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
154K acquired · 14.16K disposed
Non-Derivative Transactions2
Ordinary Shares
Direct
Shares
−14.16K
Price / share
$24.57
Trade value
$347.86K
% of position
11.6%
2/1/2026
122.28K→108.12K
Ordinary Shares
Direct
Shares
+31K
Price / share
—
Trade value
—
% of position
28.7%
2/2/2026
108.12K→139.12K
Total
Net shares
+16.84K
Net value
-$347.86K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 2/1/2026 | F · Tax Withholding | −14.16K | $24.57 | $347.86K | 11.6% | 122.28K | 108.12K |
| Ordinary Shares Direct | 2/2/2026 | A · Award | +31K | — | — | 28.7% | 108.12K | 139.12K |
| Total | +16.84K | -$347.86K | ||||||
Derivative Transactions1
Share Option (right to buy)
Direct
Converts to
Ordinary Shares
123K shares
Shares
+123K
Strike price
25.19
Held after
123K
Exercisable
—
2/2/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Share Option (right to buy) Direct | Ordinary Shares123K shares | 2/2/2026 | A · Award | +123K | 25.19 | — | 123K |